Publications by authors named "M Libanore"
Objective: Investigating the experiences perceived by COVID-19 inpatients is a fundamental research area that is starting to be explored. For this reason, our objective was to provide the first Italian survey on COVID-19 inpatients' satisfaction, obtained through a self-completed questionnaire previously used in a reference study in a UK cohort of COVID-19 patients.
Subjects And Methods: Hospitalized COVID-19 patients (>20 days) admitted to Ferrara University Hospital who underwent rehabilitation during their hospital stay were invited to complete an anonymous questionnaire.
Article Synopsis
- The GRAd-COV2 vaccine, developed from a gorilla adenovirus, aims to enhance COVID-19 immunity with a focus on a stable spike protein.
- In a phase 2 trial with 917 participants, the vaccine demonstrated good safety and strong immune responses, especially after a second dose.
- The vaccine effectively generated a robust T cell response, particularly CD8 T cells, suggesting its potential for future genetic vaccine development in combating variants of concern.
Introduction: The pathophysiology of the Corona Virus Disease 2019 (COVID-19) is incompletely known. A robust inflammatory response caused by viral replication is a main cause of the acute lung and multiorgan injury observed in critical patients. Inflammasomes are likely players in COVID-19 pathogenesis.
View Article and Find Full Text PDFArticle Synopsis
- Skin and soft tissue infections (SSTIs) are diverse conditions impacting skin and underlying tissues, with varied symptoms, severity, and causes.
- A nationwide surveillance program in Italy aimed to gather extensive data on SSTIs, involving both inpatient and outpatient cases for a comprehensive analysis of clinical and microbiological aspects.
- Over a three-year period, 478 adult patients were studied, focusing on infection types, pathogens, antimicrobial susceptibilities, co-morbidities, treatment duration, and length of hospital stay to enhance understanding of SSTI management in Italy.
The human oral microbiome (HOM) is the second largest microbial community after the gut and can impact the onset and progression of several localized and systemic diseases, including those of viral origin, especially for viruses entering the body via the oropharynx. However, this important aspect has not been clarified for the new pandemic human coronavirus SARS-CoV-2, causing COVID-19 disease, despite it being one of the many respiratory viruses having the oropharynx as the primary site of replication. In particular, no data are available about the non-bacterial components of the HOM (fungi, viruses), which instead has been shown to be crucial for other diseases.
View Article and Find Full Text PDF